FDA Orange Book
Is there a generic for Vabomere?
Vabomere contains meropenem and vaborbactam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vabomere (meropenem and vaborbactam). The Orange Book shows its last listed patent expires April 6, 2039 and its last listed exclusivity ends August 29, 2027.
Run it in Rivvi
Map Vabomere and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vabomere products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| powder, intravenous | 1GM/VIAL;1GM/VIAL | Marketed (Rx) | None | 0 | None |
NDA 209776, held by REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Vabomere patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9694025 | August 8, 2031 | Method of use | U-2120 | 209776 |
| 10561675 | August 8, 2031 | Method of use | U-2490 | 209776 |
| 10183034 | August 8, 2031 | Method of use | U-2490 | 209776 |
| 11007206 | August 8, 2031 | Method of use | U-3128 | 209776 |
| 12171772 | August 8, 2031 | Drug substance | None | 209776 |
| 10172874 | August 8, 2031 | Drug product | None | 209776 |
| 8680136 | August 29, 2031 | Drug substance, Drug product | None | 209776 |
| 12478606 | January 8, 2038 | Method of use | U-3421 | 209776 |
| 11376237 | April 6, 2039 | Method of use | U-3421 | 209776 |
| 12533342 | April 6, 2039 | Method of use | U-3421 | 209776 |
Vabomere exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | August 29, 2022 | 209776 |
| GAIN | Generating Antibiotic Incentives Now | August 29, 2027 | 209776 |
Vabomere NDC codes
Questions
Is there a generic for Vabomere?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vabomere (meropenem and vaborbactam). The Orange Book shows its last listed patent expires April 6, 2039 and its last listed exclusivity ends August 29, 2027.
What is the generic name for Vabomere?
The active ingredient in Vabomere is meropenem and vaborbactam, per the FDA Orange Book.
When does the Vabomere patent expire?
The last patent listed for Vabomere in the Orange Book expires April 6, 2039. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.